Skip to main content
. 2022 Jun 6;68(4):fmac046. doi: 10.1093/tropej/fmac046

Table 2.

Comparison of the laboratory findings of the patients

Total (n: 93) COVID-19 (+) (n: 27) COVID-19 (−) (n: 66) p-Value
CRP, median (IQR), mg/l 3.1 (2.9–11.47) 2.9 (1.5–3.1) 4.5 (2.9–15.1) <0.001 a
WBC, mean±SD, × 109/l 9.92 ± 4.61 7.45 ± 2.51 10.93 ± 4.90 <0.001 b
ALC, median (IQR), × 109/l 4.3 (3.02–4.34) 3.63 (2.62–4.88) 5.07 (3.28–6.27) 0.015 a
ANC, mean±SD, × 109/l 3.67 ± 3.05 2.21 ± 1.08 4.27 ± 3.38 <0.001 b
SII, mean±SD, × 109/l 350.19 ± 316.7 201.14 ± 98.08 411.16 ± 353.73 <0.001 b
IG %, median (IQR) 0.3 (0.2–0.5) 0.3 (0.3–0.4) 0.3 (0.2–0.5) 0.361a
NLR, median (IQR) 0.59 (0.35–1.26) 0.59 (0.33–0.82) 0.59 (0.35–1.36) 0.203a
Leukopenia (%) 9 (9.7%) 3 (11.3%) 6 (9.1%) 0.716c
Lymphopenia (%) 13 (14%) 6 (22.2%) 7 (10.6%) 0.188c
Neutropenia (%) 8 (8.6%) 2 (7.4%) 6 (9.1%) 0.793c

Bold values are statistically significant.

a

Mann–Whitney U-test.

b

Independent t-test.

c

Chi-square test.

CRP, C-reactive protein; IG, immature granulocytes; SII, systemic immune-inflammation index; WBC, white blood cell; ALC, absolute lymphocyte count; ANC, absolute neutrophil count; NLR, neutrophil–lymphocyte ratio; SD, standard deviation; IQR, interquartile range.